Malin Berglund
Research Engineer at Department of Medical Sciences; Cancer Pharmacology and Computational Medicine
- E-mail:
- malin.berglund@medsci.uu.se
- Visiting address:
- Akademiska sjukhuset, ingång 61
- Postal address:
- Akademiska sjukhuset, ingång 61
751 85 Uppsala
Publications
Recent publications
Part of SLAS TECHNOLOGY, 2024
- DOI for Exploratory insights from the immuno-oncology hollow fiber assay: A pilot approach bridging In Vitro and In Vivo models
- Download full text (pdf) of Exploratory insights from the immuno-oncology hollow fiber assay: A pilot approach bridging In Vitro and In Vivo models
Part of BMC Pharmacology & Toxicology, 2024
- DOI for Immuno-oncological effects of standard anticancer agents and commonly used concomitant drugs: an in vitro assessment
- Download full text (pdf) of Immuno-oncological effects of standard anticancer agents and commonly used concomitant drugs: an in vitro assessment
Part of BMC Cancer, 2023
- DOI for Phenotypic screening platform identifies statins as enhancers of immune cell-induced cancer cell death
- Download full text (pdf) of Phenotypic screening platform identifies statins as enhancers of immune cell-induced cancer cell death
Part of Cytokine, 2021
- DOI for Increased levels of plasma cytokines and correlations to organ failure and 30-day mortality in critically ill Covid-19 patients
- Download full text (pdf) of Increased levels of plasma cytokines and correlations to organ failure and 30-day mortality in critically ill Covid-19 patients
Mebendazole is unique among tubulin-active drugs in activating the MEK-ERK pathway
Part of Scientific Reports, 2020
- DOI for Mebendazole is unique among tubulin-active drugs in activating the MEK-ERK pathway
- Download full text (pdf) of Mebendazole is unique among tubulin-active drugs in activating the MEK-ERK pathway
All publications
Articles in journal
Part of SLAS TECHNOLOGY, 2024
- DOI for Exploratory insights from the immuno-oncology hollow fiber assay: A pilot approach bridging In Vitro and In Vivo models
- Download full text (pdf) of Exploratory insights from the immuno-oncology hollow fiber assay: A pilot approach bridging In Vitro and In Vivo models
Part of BMC Pharmacology & Toxicology, 2024
- DOI for Immuno-oncological effects of standard anticancer agents and commonly used concomitant drugs: an in vitro assessment
- Download full text (pdf) of Immuno-oncological effects of standard anticancer agents and commonly used concomitant drugs: an in vitro assessment
Part of BMC Cancer, 2023
- DOI for Phenotypic screening platform identifies statins as enhancers of immune cell-induced cancer cell death
- Download full text (pdf) of Phenotypic screening platform identifies statins as enhancers of immune cell-induced cancer cell death
Part of Cytokine, 2021
- DOI for Increased levels of plasma cytokines and correlations to organ failure and 30-day mortality in critically ill Covid-19 patients
- Download full text (pdf) of Increased levels of plasma cytokines and correlations to organ failure and 30-day mortality in critically ill Covid-19 patients
Mebendazole is unique among tubulin-active drugs in activating the MEK-ERK pathway
Part of Scientific Reports, 2020
- DOI for Mebendazole is unique among tubulin-active drugs in activating the MEK-ERK pathway
- Download full text (pdf) of Mebendazole is unique among tubulin-active drugs in activating the MEK-ERK pathway
Mebendazole-induced M1 polarisation of THP-1 macrophages may involve DYRK1B inhibition
Part of BMC Research Notes, 2019
- DOI for Mebendazole-induced M1 polarisation of THP-1 macrophages may involve DYRK1B inhibition
- Download full text (pdf) of Mebendazole-induced M1 polarisation of THP-1 macrophages may involve DYRK1B inhibition
Part of Immunopharmacology and immunotoxicology, p. 199-210, 2017
Part of Cell Reports, p. 2994-3009, 2016
- DOI for Clonal Variation in Drug and Radiation Response among Glioma-Initiating Cells Is Linked to Proneural-Mesenchymal Transition
- Download full text (pdf) of Clonal Variation in Drug and Radiation Response among Glioma-Initiating Cells Is Linked to Proneural-Mesenchymal Transition